id: NEW:psychosocial_therapy_access_barriers_to_NEW:ptsd_sud_treatment_gap
name: Psychosocial Therapy Access Barriers â†’ PTSD-SUD Treatment Gap
from_node:
  node_id: NEW:psychosocial_therapy_access_barriers
  node_name: Psychosocial Therapy Access Barriers
to_node:
  node_id: NEW:ptsd_sud_treatment_gap
  node_name: PTSD-SUD Treatment Gap
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Psychosocial therapies are currently the only specifically recommended treatments for co-occurring
  PTSD and SUD'
- 'Step 2: These therapies face numerous structural barriers to access including availability, cost, time
  requirements, and workforce shortages'
- 'Step 3: Engagement barriers include stigma, transportation, scheduling conflicts, and treatment complexity'
- 'Step 4: Limited treatment options result in untreated or undertreated co-occurring conditions with
  worse outcomes'
evidence:
  quality_rating: A
  n_studies: 29
  primary_citation: 'Megan Swannell et al. 2025. "Pharmacological treatments for co-occurring PTSD and
    substance use disorders: A systematic review.." https://doi.org/10.1016/j.josat.2024.209601'
  supporting_citations:
  - Additional citations require full-text access - systematic review methodology
  - Review encompasses RCTs, observational studies, case-control, and cohort studies
  - 16 pharmacotherapies examined across 29 included studies
  doi: 10.1016/j.josat.2024.209601
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: The review identifies that currently only psychosocial therapies are specifically recommended
  for co-occurring PTSD and SUD, but these face 'numerous barriers to access and engagement.' This creates
  a treatment gap that pharmacological options could help address.
spatial_variation:
  varies_by_geography: true
  variation_notes: Access barriers likely vary significantly by geography, with rural areas having fewer
    mental health and addiction specialists, and civilian populations having different access patterns
    than veterans with VA healthcare
moderators:
- name: civilian_vs_veteran_status
  direction: strengthens
  strength: strong
  description: Civilian populations may face greater access barriers than veterans who have access to
    VA healthcare system; review calls for more civilian-focused research
- name: substance_type
  direction: strengthens
  strength: moderate
  description: Review notes majority of studies focused on alcohol use disorders, with less evidence for
    other SUDs potentially reflecting treatment system gaps
structural_competency:
  equity_implications: This mechanism highlights healthcare system inadequacy as a structural determinant
    of health outcomes. The treatment gap is not due to individual non-compliance but to systemic barriers
    in treatment availability and accessibility. The review explicitly calls for expanded pharmacological
    options to address these structural barriers, recognizing that relying solely on therapy-based approaches
    creates inequitable access.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:36.733852'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
